Vantix Diagnostics is a pioneering company that has been dedicated to precise detection in medical, veterinary, and environmental diagnostics since 2010. The company is headquartered in Pelham, New Hampshire, and offers a versatile biosensor platform called Vantix. This platform is designed for the medical, veterinary, and environmental sectors, allowing for the detection and measurement of toxins, drugs, contaminants, proteins, and nucleic acids. It provides accurate readings from biological samples like blood, urine, and saliva, as well as from complex samples such as milk, river water, and homogenized grain. The company recently received a $4.95M Venture Round investment on 11 February 2014 from Chord Capital. Vantix Diagnostics has shown great potential in the hardware industry by developing a cutting-edge technology that addresses crucial needs in various sectors. With its innovative approach and strong investor backing, Vantix Diagnostics is well-positioned to make significant strides in the field of diagnostics and biosensor platforms.
No recent news or press coverage available for vantix® DIAGNOSTICS, Inc.